ABD - İngilizce - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine tablets are indicated in adults for the treatment of: - major depressive disorder (mdd) - obsessive compulsive disorder (ocd) - panic disorder (pd) - social anxiety disorder (sad) - generalized anxiety disorder (gad) - posttraumatic stress disorder (ptsd) - concomitant use of monoamine oxidase inhibitors (maois) or use within 14 days of discontinuing a maoi. ( 4, 5.3, 7) - concomitant use of pimozide or thioridazine. ( 4, 5.3, 7) - known hypersensitivity to paroxetine or to any of the inactive ingredients in paroxetine tablets. ( 4) paroxetine tablets are contraindicated in patients: - taking, or within 14 days of stopping, maois (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions ( 5.2), drug interactions ( 7)]. - taking thioridazine because of risk of qt prolongation [see warnings and precautions ( 5.3) and drug interactions ( 7)] - taking pimozide be

ABD - İngilizce - NLM (National Library of Medicine)

direct_rx - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine tablets are indicated in adults for the treatment of: major depressive disorder (mdd) obsessive compulsive disorder (ocd) panic disorder (pd) social anxiety disorder (sad) generalized anxiety disorder (gad) posttraumatic stress disorder (ptsd) paroxetine tablets are contraindicated in patients: taking, or within 14 days of stopping, maois (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7)]. taking thioridazine because of risk of qt prolongation [see warnings and precautions (5.3) and drug interactions (7)] taking pimozide because of risk of qt prolongation [see warnings and precautions (5.3), drug interactions (7)]. with known hypersensitivity (e.g., anaphylaxis, angioedema, stevens-johnson syndrome) to paroxetine or any of the inactive ingredients in paroxetine tablets [see adverse reactions (6.1), (6.2)]. 8.1 pregnancy [see warnings and

Singapur - İngilizce - HSA (Health Sciences Authority)

apex pharma marketing pte. ltd. - lithium carbonate - tablet, film coated - 400 mg - lithium carbonate 400 mg

İsrail - İngilizce - Ministry of Health

lundbeck israel ltd. - citalopram as hydrobromide - film coated tablets - citalopram as hydrobromide 20 mg - citalopram - citalopram - for the treatment of states of depression and panic disorder.

İsrail - İngilizce - Ministry of Health

lundbeck israel ltd. - citalopram as hydrobromide - film coated tablets - citalopram as hydrobromide 40 mg - citalopram - citalopram - for the treatment of states of depresion and panic disorder.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lundbeck ( ireland ) limited - citalopram - film-coated tablet - 10 milligram(s) - selective serotonin reuptake inhibitors; citalopram

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

imbat limited - citalopram hydrobromide - film-coated tablet - 20 milligram(s) - selective serotonin reuptake inhibitors; sertraline

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lundbeck ( ireland ) limited - citalopram - film-coated tablet - 20 milligram(s) - selective serotonin reuptake inhibitors; citalopram

Kanada - İngilizce - Health Canada

wyeth canada - venlafaxine (venlafaxine hydrochloride) - tablet - 75mg - venlafaxine (venlafaxine hydrochloride) 75mg - selective serotonin and norepinephrine-reuptake inhibitors

Kanada - İngilizce - Health Canada

wyeth canada - venlafaxine (venlafaxine hydrochloride) - tablet - 37.5mg - venlafaxine (venlafaxine hydrochloride) 37.5mg - selective serotonin and norepinephrine-reuptake inhibitors